Beam Therapeutics Inc. / Estimates

    Fiscal Year Revenue Net income Net margin Free cash flow FCF margin
    (estimated) €385.48M +283.9% -€296.53M -32.8% -76.9% +3.6 pp -€49.77M -72.0% -12.9% +1.6 pp
    (estimated) €100.40M +69.1% -€441.37M -3.8% -439.6% +3.3 pp -€177.88M -36.0% -177.2% +2.9 pp
    (estimated) €59.36M +58.5% -€458.81M +11.2% -773.0% +3.3 pp -€277.94M -1.9% -468.3% +2.9 pp
    (estimated) €37.45M -1.3% -€412.42M +12.5% -1,101.2% -1.4 pp -€283.41M +0.7% -756.7% -0.16 pp
    (estimated) €37.96M -29.9% -€366.46M +14.0% -965.3% -3.7 pp -€281.38M -2.5% -741.2% -2.1 pp
    €54.18M -83.2% -€321.34M +184.3% -593.1% -5.6 pp -€288.55M +193.0% -532.6% -5.0 pp
    €322.17M +520.0% -€113.04M -49.7% -35.1% +4.0 pp -€98.48M -261.5% -30.6% -1.5 pp
    €51.96M +17.5% -€224.83M -22.8% -432.7% +2.3 pp €60.97M -467.4% 117.3% +1.5 pp
    €44.22M +215,916.7% -€291.16M +33.1% -658.4% +11K pp -€16.60M -75.5% -37.5% +3.3K pp
    €20.47K +33.3% -€218.72M +226.9% -1,068,433.3% -6.3K pp -€67.71M +33.5% -330,766.7% -2.9 pp
    €15.35K +∞% -€66.91M -31.9% -435,788.9% -4.4K pp -€50.74M +729.2% -330,472.2% -3.3K pp
    €0.00 +NaN% -€98.31M +1,340.4% N/A -€6.12M +203.9% N/A
    €0.00 -€6.83M N/A -€2.01M N/A

    Notifications